2018 Volume 32 Issue 7 Pages 837-841
There is no consensus regarding limited surgery for small lung cancer, and clinical trials are currently ongoing. Adenocarcinoma in situ (AIS) has been reported to be associated with a good prognosis, with a 100% 5-year survival rate. The present case involved a patient in whom CT showed a ground glass opacity (GGO) lesion in right S1 of 10 mm. The lesion grew gradually each year, forming a partly solid nodule by year 3 and a solid nodule of 16 mm after 5 years; the patient was then referred to our hospital. We performed limited surgery for this patient. The pathological diagnosis was AIS, and now at 7 years since the surgery, recurrence has not been detected. We observed changes in the GGO lesion with time over 5 years, and suggest that AIS may appear as solid nodules on computed tomography and that limited resection is a possible treatment.